Published in Infect Immun on July 30, 2012
The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. J Bacteriol (2013) 1.00
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
The agr locus regulates virulence and colonization genes in Clostridium difficile 027. J Bacteriol (2013) 0.95
The role of flagella in Clostridium difficile pathogenesis: comparison between a non-epidemic and an epidemic strain. PLoS One (2013) 0.93
Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile. J Bacteriol (2014) 0.91
Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol (2016) 0.90
Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR. PLoS One (2013) 0.89
Genetically diverse Clostridium difficile strains harboring abundant prophages in an estuarine environment. Appl Environ Microbiol (2013) 0.88
The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection. PLoS One (2014) 0.86
Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen. Gut Microbes (2014) 0.86
SecDF as part of the Sec-translocase facilitates efficient secretion of Bacillus cereus toxins and cell wall-associated proteins. PLoS One (2014) 0.82
The post-translational modification of the Clostridium difficile flagellin affects motility, cell surface properties and virulence. Mol Microbiol (2014) 0.82
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC. Emerg Microbes Infect (2016) 0.80
Identification and characterization of glycoproteins on the spore surface of Clostridium difficile. J Bacteriol (2014) 0.79
Cyclic-di-GMP signaling in the Gram-positive pathogen Clostridium difficile. Curr Genet (2015) 0.78
The Regulatory Networks That Control Clostridium difficile Toxin Synthesis. Toxins (Basel) (2016) 0.78
The HtrA-like protease CD3284 modulates virulence of Clostridium difficile. Infect Immun (2014) 0.77
Cyclic diguanylate signaling in Gram-positive bacteria. FEMS Microbiol Rev (2016) 0.77
What's a SNP between friends: The influence of single nucleotide polymorphisms on virulence and phenotypes of Clostridium difficile strain 630 and derivatives. Virulence (2016) 0.76
As Clear as Mud? Determining the Diversity and Prevalence of Prophages in the Draft Genomes of Estuarine Isolates of Clostridium difficile. Genome Biol Evol (2015) 0.76
The Phosphotransfer Protein CD1492 Represses Sporulation Initiation in Clostridium difficile. Infect Immun (2016) 0.75
A genetic switch controls the production of flagella and toxins in Clostridium difficile. PLoS Genet (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics (2010) 6.57
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression. Infect Immun (1996) 4.14
Coordinating assembly of a bacterial macromolecular machine. Nat Rev Microbiol (2008) 3.86
Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis (1999) 3.71
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol (2009) 3.66
The ClosTron: Mutagenesis in Clostridium refined and streamlined. J Microbiol Methods (2009) 3.16
The Bacillus subtilis flagellin gene (hag) is transcribed by the sigma 28 form of RNA polymerase. J Bacteriol (1989) 3.00
Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori. J Med Microbiol (1992) 2.92
Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol Microbiol (1994) 2.78
Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models. Infect Immun (1991) 2.77
Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol (2010) 2.61
The bacterial flagellum: reversible rotary propellor and type III export apparatus. J Bacteriol (1999) 2.48
Repression of Clostridium difficile toxin gene expression by CodY. Mol Microbiol (2007) 2.28
Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol (1998) 2.28
Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem (1997) 2.25
Secretion of virulence proteins from Campylobacter jejuni is dependent on a functional flagellar export apparatus. J Bacteriol (2004) 2.20
Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect Immun (2006) 2.09
Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol (2007) 2.05
Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A (2001) 1.89
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol (2006) 1.71
LocateP: genome-scale subcellular-location predictor for bacterial proteins. BMC Bioinformatics (2008) 1.64
Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing. Proc Natl Acad Sci U S A (2008) 1.63
Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol (2009) 1.57
Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun (2002) 1.55
Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J Clin Microbiol (2009) 1.48
The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors. J Bacteriol (2009) 1.45
Motility and flagellar glycosylation in Clostridium difficile. J Bacteriol (2009) 1.45
Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J Clin Invest (1997) 1.39
Gene position in a long operon governs motility development in Bacillus subtilis. Mol Microbiol (2010) 1.35
CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol Microbiol (2010) 1.30
The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J Bacteriol (2011) 1.30
Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J Infect Dis (2007) 1.29
Relative roles of the fla/che P(A), P(D-3), and P(sigD) promoters in regulating motility and sigD expression in Bacillus subtilis. J Bacteriol (2000) 1.20
Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J Biol Chem (2011) 1.19
The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol (2011) 1.14
Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog (2012) 1.12
Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters. Infect Immun (2011) 1.09
ClosTron-targeted mutagenesis. Methods Mol Biol (2010) 1.03
Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Microb Pathog (2011) 0.97
A Vibrio cholerae relaxed (relA) mutant expresses major virulence factors, exhibits biofilm formation and motility, and colonizes the suckling mouse intestine. J Bacteriol (2006) 0.92
Evaluation of candidate reference genes in Clostridium difficile for gene expression normalization. Anaerobe (2010) 0.92
LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile. Biochem Biophys Res Commun (2005) 0.86
Coordinated regulation of virulence by quorum sensing and motility pathways during the initial stages of Vibrio cholerae infection. Commun Integr Biol (2008) 0.84
Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination. Int J Med Microbiol (2011) 0.82
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology (2002) 5.50
Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A (2005) 3.35
Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb Pathog (2003) 2.61
A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun (2005) 2.53
Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics (2009) 2.50
Campylobacter--a tale of two protein glycosylation systems. Trends Microbiol (2003) 2.10
Identification of genes involved in the biosynthesis and attachment of Methanococcus voltae N-linked glycans: insight into N-linked glycosylation pathways in Archaea. Mol Microbiol (2006) 1.82
Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS. Microb Pathog (2002) 1.80
Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun (2007) 1.77
Functional characterization of dehydratase/aminotransferase pairs from Helicobacter and Campylobacter: enzymes distinguishing the pseudaminic acid and bacillosamine biosynthetic pathways. J Biol Chem (2005) 1.76
Large-scale comparative genomics meta-analysis of Campylobacter jejuni isolates reveals low level of genome plasticity. J Clin Microbiol (2004) 1.75
Pseudaminic acid, the major modification on Campylobacter flagellin, is synthesized via the Cj1293 gene. Mol Microbiol (2003) 1.62
Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis. Infect Immun (2004) 1.61
Identification and characterization of the unique N-linked glycan common to the flagellins and S-layer glycoprotein of Methanococcus voltae. J Biol Chem (2005) 1.60
Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: gene-environment interaction. Ann Neurol (2010) 1.55
Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. Microb Pathog (2004) 1.50
Motility and flagellar glycosylation in Clostridium difficile. J Bacteriol (2009) 1.45
Fibrin-mediated protection against infection-stimulated immunopathology. J Exp Med (2003) 1.43
Structural and functional characterization of PseC, an aminotransferase involved in the biosynthesis of pseudaminic acid, an essential flagellar modification in Helicobacter pylori. J Biol Chem (2006) 1.36
Campylobacter jejuni glycosylation island important in cell charge, legionaminic acid biosynthesis, and colonization of chickens. Infect Immun (2009) 1.35
Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins. Anal Chem (2005) 1.34
Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis. J Med Microbiol (2006) 1.29
Virulence comparison in mice of distinct isolates of type A Francisella tularensis. Microb Pathog (2006) 1.28
Elucidation of the CMP-pseudaminic acid pathway in Helicobacter pylori: synthesis from UDP-N-acetylglucosamine by a single enzymatic reaction. Glycobiology (2006) 1.28
Functional characterization of the flagellar glycosylation locus in Campylobacter jejuni 81-176 using a focused metabolomics approach. J Biol Chem (2006) 1.27
Identification of genes involved in the assembly and attachment of a novel flagellin N-linked tetrasaccharide important for motility in the archaeon Methanococcus maripaludis. Mol Microbiol (2009) 1.26
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. Vaccine (2007) 1.24
Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection. J Immunol (2009) 1.22
Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J Mol Biol (2004) 1.21
Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J Biol Chem (2011) 1.19
Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J (2001) 1.19
Flagellar glycosylation in Clostridium botulinum. FEBS J (2008) 1.18
Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis. Mol Immunol (2008) 1.16
Flagellin diversity in Clostridium botulinum groups I and II: a new strategy for strain identification. Appl Environ Microbiol (2007) 1.16
Prokaryotic expression of antibodies. Cancer Metastasis Rev (2005) 1.15
Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis. Microb Pathog (2004) 1.15
Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect Immun (2005) 1.15
Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy. PLoS One (2010) 1.13
The CMP-legionaminic acid pathway in Campylobacter: biosynthesis involving novel GDP-linked precursors. Glycobiology (2009) 1.13
Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS One (2012) 1.12
Glycosylation of b-Type flagellin of Pseudomonas aeruginosa: structural and genetic basis. J Bacteriol (2006) 1.12
Genetic and mass spectrometry analyses of the unusual type IV-like pili of the archaeon Methanococcus maripaludis. J Bacteriol (2010) 1.12
AglC and AglK are involved in biosynthesis and attachment of diacetylated glucuronic acid to the N-glycan in Methanococcus voltae. J Bacteriol (2008) 1.11
Identity-by-descent approach to gene localisation in eight individuals affected by keratoconus from north-west Tasmania, Australia. Hum Genet (2002) 1.10
A novel N-linked flagellar glycan from Methanococcus maripaludis. Carbohydr Res (2009) 1.10
Targeted metabolomics analysis of Campylobacter coli VC167 reveals legionaminic acid derivatives as novel flagellar glycans. J Biol Chem (2007) 1.08
High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect (2009) 1.07
Role of Toll-like receptors in health and diseases of gastrointestinal tract. World J Gastroenterol (2006) 1.06
Intestinal M cells: the fallible sentinels? World J Gastroenterol (2007) 1.05
In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii. Antimicrob Agents Chemother (2012) 1.04
Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae. Proc Natl Acad Sci U S A (2006) 1.04
Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice. Infect Immun (2008) 1.04
Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis. Microb Pathog (2004) 1.04
Differential glycosylation of polar and lateral flagellins in Aeromonas hydrophila AH-3. J Biol Chem (2012) 0.99
Selective detection and identification of sugar nucleotides by CE-electrospray-MS and its application to bacterial metabolomics. Anal Chem (2004) 0.99
3',5'-Cyclic diguanylic acid: a small nucleotide that makes big impacts. Chem Soc Rev (2010) 0.98
Host resistance to malaria: using mouse models to explore the host response. Mamm Genome (2010) 0.98
Identification of novel glycosyltransferases required for assembly of the Pasteurella multocida A:1 lipopolysaccharide and their involvement in virulence. Infect Immun (2009) 0.98
Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice. J Immunol (2005) 0.97
Role of neutrophils and NADPH phagocyte oxidase in host defense against respiratory infection with virulent Francisella tularensis in mice. Microbes Infect (2011) 0.97
Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. J Immunol Methods (2003) 0.97
Infection of mice with Francisella as an immunological model. Curr Protoc Immunol (2011) 0.96
B-cell-targeted therapy for systemic lupus erythematosus: an update. BioDrugs (2008) 0.96
Familial focal epilepsy with variable foci mapped to chromosome 22q12: expansion of the phenotypic spectrum. Epilepsia (2012) 0.96
Methylamidation for sialoglycomics by MALDI-MS: a facile derivatization strategy for both α2,3- and α2,6-linked sialic acids. Anal Chem (2010) 0.95
Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infections. PLoS One (2010) 0.95
M cell-targeted delivery of vaccines and therapeutics. Expert Opin Drug Deliv (2008) 0.94
Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii. Vaccine (2004) 0.94
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother (2013) 0.94
Identification of single-domain, Bax-specific intrabodies that confer resistance to mammalian cells against oxidative-stress-induced apoptosis. FASEB J (2006) 0.93
Genes and susceptibility to leishmaniasis. Adv Parasitol (2005) 0.93
Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS). PLoS One (2010) 0.92
Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis. J Bacteriol (2011) 0.92
Engineered single-domain antibodies with high protease resistance and thermal stability. PLoS One (2011) 0.92
Comparative genomics profiling of clinical isolates of Aeromonas salmonicida using DNA microarrays. BMC Genomics (2006) 0.91
Current methods for molecular typing of Campylobacter species. J Microbiol Methods (2013) 0.91
Identification of labile UDP-ketosugars in Helicobacter pylori, Campylobacter jejuni and Pseudomonas aeruginosa: key metabolites used to make glycan virulence factors. Chembiochem (2006) 0.91
Transcriptional and translational expression patterns associated with immobilized growth of Campylobacter jejuni. Microbiology (2006) 0.91
Identification of genes involved in the acetamidino group modification of the flagellin N-linked glycan of Methanococcus maripaludis. J Bacteriol (2012) 0.90
Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile. J Biol Chem (2013) 0.90
Bacteriophage tailspike proteins as molecular probes for sensitive and selective bacterial detection. Biosens Bioelectron (2010) 0.90